Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Size: px
Start display at page:

Download "Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile"

Transcription

1 Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

2 Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business Research Store is run by Sector Publishing Intelligence Ltd. SPi has been selling professional market research reports and company analyses for over 7 years. Our experienced staff team are on hand to help with any research enquiries you may have, and help you find the right report for your needs. We sell reports to businesses of all sizes across the world who need current market data to plan and develop their business strategies. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or office@sectorpublishing.com 2

3 Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Atreca Inc (Atreca) is a biotechnology company that develops novel therapies based on the human immune response. The company offers therapeutic programs which are focused on cancer immunotherapy s which also includes therapeutics that optimizes the anti-tumor immune responses and infectious diseases. Its proprietary Immune Repertoire Capture (IRC) technology provides unbiased and virtually error-free antibody and T cell receptor (TCR) sequences from the adaptive immune responses. The company s technology is licensed in partnerships with pharmaceutical companies, non-profit foundations, academic institutions and the US Government. It seeks to work in collaboration with other organizations for target discovery, immune profiling, discovery and development of antibody-based therapeutics, vaccines and diagnostics for various therapeutic areas. Atreca is headquartered in Redwood City, California, the US. Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. 3

4 - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH431798D Number of Pages : 21 Report Format : PDF Publisher Information : 4

5 5

6 Table Of Contents for Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: ] Table of Contents Table of Contents 3List of Tables 4List of Figures 4Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deal Details 10Venture Financing 10Atreca Raises USD35 Million in Series B Financing 10Atreca Raises USD56 Million in Series A Financing 11Atreca Raises USD57.26 Million in Venture Financing 12Partnerships 13Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 13Atreca Enters into Agreement with Genome Institute of Singapore 14Atreca Enters into Research Agreement with Janssen Biotech 15Atreca Enters into Agreement with Bill & Melinda Gates Foundation 16Licensing Agreements 17Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 17Atreca Inc - Key Competitors 18Atreca Inc - Key Employees 19Atreca Inc - Locations And Subsidiaries 20Head Office 20Appendix 21Methodology 21About GlobalData 21Contact Us 21Disclaimer 21 6

7 List Of Tables in Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: ] List of Tables Atreca Inc, Pharmaceuticals & Healthcare, Key Facts 2 Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD Atreca Inc, Deals By Therapy Area, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD Atreca Raises USD35 Million in Series B Financing 10 Atreca Raises USD56 Million in Series A Financing 11 Atreca Raises USD57.26 Million in Venture Financing 12 Atreca and Dana-Farber Cancer Institute Enter into R&D Agreement 13 Atreca Enters into Agreement with Genome Institute of Singapore 14 Atreca Enters into Research Agreement with Janssen Biotech 15 Atreca Enters into Agreement with Bill & Melinda Gates Foundation 16 Atreca Enters Into Licensing Agreement With Stanford University For Immune Repertoire Capture Technology 17 Atreca Inc, Key Competitors 18 Atreca Inc, Key Employees 19 7

8 List Of Figures, Charts and Diagrams in Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: ] List of Figures Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD Atreca Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD

9 How to Buy... Atreca Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: ] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at office@sectorpublishing.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9

Specialised Therapeutics Australia Pty. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Specialised Therapeutics Australia Pty. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Specialised Therapeutics Australia Pty. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Specialised Therapeutics Australia Pty. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances

More information

Lockheed Martin Missiles and Fire Control - Strategy, SWOT and Corporate Finance Report

Lockheed Martin Missiles and Fire Control - Strategy, SWOT and Corporate Finance Report Lockheed Martin Missiles and Fire Control - Strategy, SWOT and Corporate Finance Report Lockheed Martin Missiles and Fire Control - Strategy, SWOT and Corporate Finance Report The Business Research Store

More information

DEC - Riyadh PP11 Gas Fired Power Plant - Saudi Arabia - Construction Project Profile

DEC - Riyadh PP11 Gas Fired Power Plant - Saudi Arabia - Construction Project Profile DEC - Riyadh PP11 Gas Fired Power Plant - Saudi Arabia - Construction Project Profile DEC - Riyadh PP11 Gas Fired Power Plant - Saudi Arabia - Construction Project Profile Sector Publishing Intelligence

More information

Alopecia - Pipeline Review, H2 2015

Alopecia - Pipeline Review, H2 2015 Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Alopecia - Pipeline Review, H2 2015 Alopecia - Pipeline Review, H2 2015 Publication ID: GMD0915178 Publication September

More information

Massachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry

Massachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry Massachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry Massachusetts State Profile 5 Key Programs & Initiatives The opportunities generated by the biopharmaceutical sector as a leader

More information

BIOMINAS BRASIL. Your ideal partner to succeed in life sciences in Latin America Dedicated to create and develop business in life sciences since 1990

BIOMINAS BRASIL. Your ideal partner to succeed in life sciences in Latin America Dedicated to create and develop business in life sciences since 1990 BIOMINAS BRASIL Your ideal partner to succeed in life sciences in Latin America Dedicated to create and develop business in life sciences since 1990 BIOMINAS BRASIL ACTIVITIES ARE DISTRIBUTED IN FOUR MAIN

More information

Global Location Trends: Asia-Pacific Facts & Figures

Global Location Trends: Asia-Pacific Facts & Figures IBM Global Business Services November 2012 Global Location Trends: Asia-Pacific Facts & Figures Table of Contents (1/4) Chapter 1: Leading sectors and activities for foreign investment 1.1 Top investing

More information

REFERENCE CODE GDHC1184DFR PUBLICATION DATE JUNE 2013

REFERENCE CODE GDHC1184DFR PUBLICATION DATE JUNE 2013 REFERENCE CODE GDHC1184DFR PUBLICATION DATE JUNE 2013 LULICONAZOLE (DERMATOPHYTIC ONYCHOMYCOSIS) Executive Summary Luliconazole: Key Metrics in the US Market 2022 Market Sales US $94.52m Key events (2012

More information

AST Research Network Career Development Grants: 2019 Faculty Development Research Grant

AST Research Network Career Development Grants: 2019 Faculty Development Research Grant AST Research Network Career Development Grants: 2019 Faculty Development Research Grant The application deadline is 11:59 pm Pacific Standard Time on Wednesday, November 1, 2018. A limited number of grants

More information

Forward-Looking Statements

Forward-Looking Statements Forward-Looking Statements This presentation may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks,

More information

Pharma Investment in Digital Health: Strategies for success

Pharma Investment in Digital Health: Strategies for success A FirstWord ExpertViews Dossier Report Request Access To This Report HERE Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or

More information

Program Evaluation. Kenneth M. Portier, PhD. Director of Statistics American Cancer Society NHO Statistics & Evaluation Center (SEC)

Program Evaluation. Kenneth M. Portier, PhD. Director of Statistics American Cancer Society NHO Statistics & Evaluation Center (SEC) Program Evaluation A 30,000 View Kenneth M. Portier, PhD. Director of Statistics American Cancer Society NHO Statistics & Evaluation Center (SEC) Who Invited the Statistician? 2 Program Evaluation is.

More information

AST Research Network Career Development Grants: 2019 Fellowship Research Grant

AST Research Network Career Development Grants: 2019 Fellowship Research Grant AST Research Network Career Development Grants: 2019 Fellowship Research Grant The application deadline is 11:59 pm Pacific Standard Time on Wednesday, November 1, 2018. A limited number of grants are

More information

ZICO HOLDINGS INC. AND STAMFORD LAW CORPORATION TO FORM JOINT VENTURE

ZICO HOLDINGS INC. AND STAMFORD LAW CORPORATION TO FORM JOINT VENTURE NEWS RELEASE ZICO HOLDINGS INC. AND STAMFORD LAW CORPORATION TO FORM JOINT VENTURE - Joint Venture Company to be 51% owned by ZICO and 49% owned by Stamford Law - Proposed Acquisition of corporate secretarial

More information

Nicole Bartley Charles Adeyanju

Nicole Bartley Charles Adeyanju Nesta Ogunmuyiwa Nicole Bartley Charles Adeyanju Hyderabad Cluster Introduction Hyderabad constitutes the fifth largest metropolitan city of India. Also the capital of southern state Andhra Pradesh, the

More information

MRC Funding and Translational Research. Dr Catriona Crombie

MRC Funding and Translational Research. Dr Catriona Crombie MRC Funding and Translational Research Dr Catriona Crombie Medical Research Council The Medical Research Council is dedicated to improving human health through the best scientific research. Its work, on

More information

The Future of the Oils and Fats Market in Egypt to 2018

The Future of the Oils and Fats Market in Egypt to 2018 1. The Future of the Oils and Fats Market in Egypt to 2018 Reference Code: FD1352MR Report Price: US$ 875 (Single Copy) www.canadean-winesandspirits.com Summary The Future of the Oils & Fats Market in

More information

The Software Industry Financial Report

The Software Industry Financial Report The Software Industry Financial Report Executive Summary Software Equity Group, L.L.C. 12220 El Camino Real Suite 320 San Diego, CA 92130 info@softwareequity.com (858) 509-2800 2015 Annual Software Industry

More information

Helping you capture new markets

Helping you capture new markets / Company Profile Timms Holding Limited is a business development consulting firm which was established in Hong Kong in 1994 with a mandate to develop Brands, Products and services from the west in the

More information

Takeda akeda Research esearch Investment, Inc. nc. 435 Tasso Street, Suite 300 Palo Alto, CA94301 USA. Tel: +1 (650)

Takeda akeda Research esearch Investment, Inc. nc. 435 Tasso Street, Suite 300 Palo Alto, CA94301 USA. Tel: +1 (650) Takeda akeda Research esearch Investment, Inc. nc. 435 Tasso Street, Suite 300 Palo Alto, CA94301 USA Tel: +1 (650) 328 2900 www.tri-takeda.com 2 3 4 5 www.tri-takeda.com Operations started April 2002

More information

Start Ups and their Impact on Smart Buildings

Start Ups and their Impact on Smart Buildings Smart Buildings Start Ups and their Impact on Smart Buildings Published: Q1 2017 StartUps and their Impact on Smart Buildings 2017 Synopsis This report will help all stakeholders and investors in the Smart

More information

REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER

REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER APPLICATION DEADLINE: 5 pm, Monday, January 22, 2018 PURPOSE The Ming Hsieh Institute aims to make USC an international

More information

What next for Life Sciences? Vir Lakshman

What next for Life Sciences? Vir Lakshman What next for Life Sciences? Vir Lakshman CEO&CFO Gipfel BioDeutschland Reutlingen, Germany 3 rd December 2015 Big pharma is making deals, not drugs FINANCIAL TIMES November, 25th 2015 Life Sciences M&A

More information

BizInsights (Ultimate Corporate Information)

BizInsights (Ultimate Corporate Information) Company Particulars BizInsights (Ultimate Corporate Information) Profile of ABC SINGAPORE PTE LTD Name : ABC SINGAPORE PTE LTD Registration / UEN : 200900000A Registration Date : 14-05-2009 Date of Change

More information

2014 ACTIVITY REPORT 2014

2014 ACTIVITY REPORT 2014 2014 ACTIVITY REPORT 014 EDITORIAL In line with the sharp increase of its partnering R&D revenues since its accreditation as a Carnot institute, CALYM has benefited from a new year of growth in 2014, reaching

More information

The global content of business

The global content of business The global content of business The Role of International Business To buy, sell and trade goods and services across national boundaries Did You Know? McDonald s serves 45 million customers a day at 29,000

More information

Modernizing Hospital Adverse Event Reporting

Modernizing Hospital Adverse Event Reporting Modernizing Hospital Adverse Event Reporting 14 December 2016 Sarah H. Stec Not Legal Advice For Informational and Educational Purposes Only Firm Overview More than 1,500 lawyers in 46 offices across 21

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION In the format provided by the authors and unedited. COMMENTARY: Emerging clean energy technology investment trends A. Bumpus and S. Comello DOI: 10.1038/NCLIMATE3306 NATURE CLIMATE CHANGE www.nature.com/natureclimatechange

More information

From Science to Value. Introduction to VIB s tech transfer activities

From Science to Value. Introduction to VIB s tech transfer activities From Science to Value Introduction to VIB s tech transfer activities VIB s mission Conduct frontline life sciences research Excellence in Science and Innovation Translate results into benefits for society

More information

Retrospective Chart Review Studies

Retrospective Chart Review Studies Retrospective Chart Review Studies Designed to fulfill requirements for real-world evidence Retrospective chart review studies are often needed in the absence of suitable healthcare databases and/or other

More information

Mediwales Finance and Funding Event:

Mediwales Finance and Funding Event: Mediwales Finance and Funding Event: Cardiff, March 22 nd 2012 Translational Research Funding for Companies Dr Tim Knott Business Development Manager, Technology Transfer The Wellcome Trust Overview of

More information

EVERY PERSON DESERVES THE CHANCE TO LIVE A HEALTHY, PRODUCTIVE LIFE.

EVERY PERSON DESERVES THE CHANCE TO LIVE A HEALTHY, PRODUCTIVE LIFE. EVERY PERSON DESERVES THE CHANCE TO LIVE A HEALTHY, PRODUCTIVE LIFE. January 27, 2012 2010 Bill & Melinda Gates Foundation 1 Our Areas of Focus US Education Global Health Global Development Polio Eradication

More information

General information. Name: Colin Sainsbury

General information. Name: Colin Sainsbury General information Name of Organisation ByrneWallace Contact information Head of Organisation Main contact Name: Catherine Guy (Managing Partner) Address: 88 Harcourt Street, Dublin 2 Telephone: 353 1

More information

Originating Component: Office of the General Counsel of the Department of Defense. Effective: February 27, Releasability:

Originating Component: Office of the General Counsel of the Department of Defense. Effective: February 27, Releasability: DOD DIRECTIVE 5000.62 REVIEW OF MERGERS, ACQUISITIONS, JOINT VENTURES, INVESTMENTS, AND STRATEGIC ALLIANCES OF MAJOR DEFENSE SUPPLIERS ON NATIONAL SECURITY AND PUBLIC INTEREST Originating Component: Office

More information

REQUEST FOR PROPOSALS August 1, 2016

REQUEST FOR PROPOSALS August 1, 2016 2016-2017 REQUEST FOR PROPOSALS August 1, 2016 The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for highimpact translational research that has the potential to

More information

BizInsights (Enhanced Essential Corporate Information)

BizInsights (Enhanced Essential Corporate Information) BizInsights (Enhanced Essential Corporate Information) Company Particulars Profile of ABC SINGAPORE PTE LTD : ABC SINGAPORE PTE LTD Registration Number / UEN : 200900000A Date of Registration : 14-05-2009

More information

USAC Schools and Libraries Program Service Provider Process

USAC Schools and Libraries Program Service Provider Process USAC Schools and Libraries Program Service Provider Process CONTENTS Summary...Page 2 Step One - Apply for a SPIN Number...Page 3 Step Two Responding to Bids...Page 8 Step Three - Negotiate a Contract

More information

TABLE OF CONTENTS. 1.2 Market Overview Introduction Industry Drivers Market Size 1-5

TABLE OF CONTENTS. 1.2 Market Overview Introduction Industry Drivers Market Size 1-5 TABLE OF CONTENTS Chapter 1: EXECUTIVE SUMMARY 1.1 Introduction 1-1 1.2 Market Overview 1-2 1.2.1 Introduction 1-2 1.2.2 Industry Drivers 1-3 1.2.3 Market Size 1-5 1.3 Summary of Customer Needs 1-6 1.3.1

More information

CAMBRIDGE ADVANCED LEADERSHIP PROGRAMME (ALP)

CAMBRIDGE ADVANCED LEADERSHIP PROGRAMME (ALP) Cambridge Judge Business School Executive Education CAMBRIDGE ADVANCED LEADERSHIP PROGRAMME (ALP) Application form Please note: This application is composed of two parts. Your application will only be

More information

BizInsights (Ultimate Business Profile)

BizInsights (Ultimate Business Profile) Company Particulars BizInsights (Ultimate Business Profile) Company Profile of ABC SINGAPORE PTE LTD : ABC SINGAPORE PTE LTD Registration / UEN : 200900000A Registration Date : 14-05-2009 () : 03-09-2012

More information

GET UP CLOSE AND PERSONAL WITH WORLD CLASS RESEARCH ENTITIES AT FRENCH SCIENCE WEEK

GET UP CLOSE AND PERSONAL WITH WORLD CLASS RESEARCH ENTITIES AT FRENCH SCIENCE WEEK MEDIA RELEASE [For immediate release] An event as part of Voilah 2015! GET UP CLOSE AND PERSONAL WITH WORLD CLASS RESEARCH ENTITIES AT FRENCH SCIENCE WEEK 20 May 2015, Singapore From 26 to 28 May 2015,

More information

Indirect Cost Policy

Indirect Cost Policy Indirect Cost Policy Effective 2/1/2017 Philosophy Indirect Cost Guidance The Bill & Melinda Gates Foundation tackles critical problems primarily affecting the world s poor and disadvantaged, and supports

More information

Collaboration 4 Cure (C4C)

Collaboration 4 Cure (C4C) Collaboration 4 Cure (C4C) 3 rd Call for Proposals from San Diego Alzheimer s Researchers: Alzheimer s San Diego, in partnership with the Salk Institute (Salk), Sanford Burnham Prebys Medical Discovery

More information

COMPANY CONSULTING Terms of Reference Development of an Open Innovation Portal for UTFSM FSM1402 Science-Based Innovation FSM1402AT8 I.

COMPANY CONSULTING Terms of Reference Development of an Open Innovation Portal for UTFSM FSM1402 Science-Based Innovation FSM1402AT8 I. COMPANY CONSULTING Terms of Reference Development of an Open Innovation Portal for UTFSM FSM1402 Science-Based Innovation FSM1402AT8 I. BACKGROUND 1.1 General overview of the project in which the Consulting

More information

Unsolicited Proposals Policy and Procedures

Unsolicited Proposals Policy and Procedures Unsolicited Proposals Policy and Procedures An unsolicited proposal is a written proposal that is submitted to the Orange County Transportation Authority (AUTHORITY) for the purpose of developing a partnership

More information

China Medical Robot Industry Report, Oct. 2015

China Medical Robot Industry Report, Oct. 2015 China Medical Robot Industry Report, 2014-2018 Oct. 2015 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight

More information

Round 8 Guidelines. Overview & Objective

Round 8 Guidelines. Overview & Objective Round 8 Guidelines Overview & Objective LaunchVic s eighth funding grant round focuses on leveraging Victoria s key strengths in the health startup sector - including in MedTech, BioTech, Pharma, Health

More information

Interim Results: Rapid Cycle Evaluation. Anna Greenberg, Director, Transformation Secretariat, MOHLTC

Interim Results: Rapid Cycle Evaluation. Anna Greenberg, Director, Transformation Secretariat, MOHLTC Interim Results: Rapid Cycle Evaluation Anna Greenberg, Director, Transformation Secretariat, MOHLTC Current Evaluation Activities Rapid Cycle Evaluation Baseline conditions Early implementation results

More information

IT Outsourcing Contracts: Crunching the Numbers

IT Outsourcing Contracts: Crunching the Numbers Research Brief IT Outsourcing Contracts: Crunching the Numbers Abstract: The average annual value of an IT outsourcing contract is $47 million and the average duration is six years, according to an analysis

More information

Wall St. Training Valuation Case Competition Competition Guide

Wall St. Training Valuation Case Competition Competition Guide Wall St. Training Valuation Case Competition 2012 Competition Guide Fall 2012 Welcome On the heels of our extremely successful inaugural case competition it is my pleasure to welcome you to the 2 nd Annual

More information

Real World Evidence in Europe

Real World Evidence in Europe Real World Evidence in Europe Jessamy Baird, RWE Director Madrid, 20 th October 2014. BEFORE I BEGIN; DISCLAIMERS: Dual perspective: Pharmaceutical: I work for Lilly, but this presentation represents my

More information

The role of national development banks un fostering SME access to finance

The role of national development banks un fostering SME access to finance The role of national development banks un fostering SME access to finance Hernando Castro. Bancoldex. Colombia Septembre de 2017 Bancoldex s Ownership Structure Generalities Incorporated as a mixed stock

More information

Strategies for attracting healthcare venture capital

Strategies for attracting healthcare venture capital Beth Silverstein MS, RAC is the Director of SciLucent, LLC, a USbased management, regulatory and technical services consulting firm dedicated to helping healthcare product companies maximise the value

More information

Perspective: Case Study Emerging Care Management Models in Developing Countries

Perspective: Case Study Emerging Care Management Models in Developing Countries Perspective: Case Study Emerging Care Management Models in Developing Countries PERSPECTIVE Sash Mukherjee # AP9296303V Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881

More information

Cancer Stem Cells. Sponsorship Cancer Stem Cells allied. 11th International Conference on

Cancer Stem Cells. Sponsorship Cancer Stem Cells allied. 11th International Conference on Cancer Stem Cells 7 Sponsorship Theme: Cancer Stem Cells: Targeting the Seeds of Cancer th International Conference on Cancer Stem Cells June -3, Dublin, Ireland Dear Prospective Sponsor/Exhibitor, Greetings

More information

Investing in Cures for Multiple Sclerosis

Investing in Cures for Multiple Sclerosis Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/investing-in-cures-for-multiple-sclerosis/3602/

More information

SUNDAY, OCTOBER 22, 2017

SUNDAY, OCTOBER 22, 2017 AACR Translational Cancer Research for Basic Scientists Workshop October 22 27, 2017 Hilton Boston Back Bay Hotel Boston, MA CHAIRS: Susan Band Horwitz, PhD, Albert Einstein College of Medicine, Bronx,

More information

PPEA Guidelines and Supporting Documents

PPEA Guidelines and Supporting Documents PPEA Guidelines and Supporting Documents APPENDIX 1: DEFINITIONS "Affected jurisdiction" means any county, city or town in which all or a portion of a qualifying project is located. "Appropriating body"

More information

# $ pages In Stock. Report Description

# $ pages In Stock. Report Description Facial Recognition Market (By Technology Type - 2D Facial Recognition, 3D Facial Recognition and Facial Analytics; By End-use Industry - Government and Utilities; Military; Homeland Security; BFSI; Retail;

More information

Innovation in Action September 2016

Innovation in Action September 2016 The Pistoia Alliance newsletter for September 2016. View this email in your browser Innovation in Action September 2016 News Project updates Diary dates 2016 President's Challenge Finalists The five finalists

More information

The Legal Business Awards 2018

The Legal Business Awards 2018 The Legal Business Awards 2018 Venue: Grosvenor House Hotel, Park Lane, London Date: 18 April 2018 Sending submissions n Please e-mail your submission to awards@legalease.co.uk n Please send only one submission

More information

Hitwise US Research Note: Measuring Web 2.0 Consumer Participation

Hitwise US Research Note: Measuring Web 2.0 Consumer Participation Hitwise US Research Note: Measuring Web 2.0 Consumer Participation June 2007 Bill Tancer General Manager, Global Research, Hitwise 1 The Growth of Web 2.0 Sites The amount of user content available on

More information

Kuraray to Acquire DuPont Glass Laminating Solutions/Vinyls

Kuraray to Acquire DuPont Glass Laminating Solutions/Vinyls Contacts: Kuraray DuPont Tomoyuki Shimamoto Carole Davies +81-3-6701-1071 +1-248-583-8112 kuraraykoho@kuraray.co.jp carole.a.davies@dupont.com Kuraray to Acquire DuPont Glass Laminating Solutions/Vinyls

More information

The Legal Business Awards 2017

The Legal Business Awards 2017 The Legal Business Awards 2017 Venue: Grosvenor House Hotel, Park Lane, London Date: 23 March 2017 Submission criteria The awards are open to UK-based lawyers at any international or domestic law firm,

More information

AN OVERVIEW OF THE CLINICAL TRIAL ENGAGEMENT NETWORK

AN OVERVIEW OF THE CLINICAL TRIAL ENGAGEMENT NETWORK AN OVERVIEW OF THE CLINICAL TRIAL ENGAGEMENT NETWORK Gary Puckrein, Ph.D. President and CEO National Minority Quality Forum Salvatore Alesci, MD, PhD VP, Scientific & Regulatory Affairs PhRMA Participation

More information

Informal note on the draft outline of the report of WHO on progress achieved in realizing the commitments made in the UN Political Declaration on NCDs

Informal note on the draft outline of the report of WHO on progress achieved in realizing the commitments made in the UN Political Declaration on NCDs Informal note on the draft outline of the report of WHO on progress achieved in realizing the commitments made in the UN Political Declaration on NCDs (NOT AN OFFICIAL DOCUMENT OR FORMAL RECORD 1 ) Geneva,

More information

Trade in Health Services and GATS. Trade in Health Services and GATS. Public health issues and WTO rules. Health and Trade

Trade in Health Services and GATS. Trade in Health Services and GATS. Public health issues and WTO rules. Health and Trade Trade in Services and Trade in Services and Nick Drager M.D., Ph.D. Senior Adviser Department of Ethics, Trade, Human Rights and Law World Organization Context: public health in a globalizing world ; trade

More information

Level 3 and tw telecom: Strengthening Level 3 s Position as a Premier Global Communications Company. Level 3 To Acquire tw telecom

Level 3 and tw telecom: Strengthening Level 3 s Position as a Premier Global Communications Company. Level 3 To Acquire tw telecom Level 3 To Acquire tw telecom June 16, 2014 tw telecom s U.S.-based, enterprise-focused business is highly complementary to Level 3 s local-to-global business and positions Level 3 as a premier provider

More information

What information does Genome.One collect about you and why?

What information does Genome.One collect about you and why? PRIVACY POLICY About this Privacy Policy 1. Genome.One Pty Ltd ACN 608 029 732 (Genome.One) appreciates that privacy is important to you. Genome.One is committed to handling personal information (including

More information

The Australian Pancreatic Cancer Genome Initiative (APGI)

The Australian Pancreatic Cancer Genome Initiative (APGI) The Australian Pancreatic Cancer Genome Initiative (APGI) BioSpecimen & Data Access Policy Version 4.4 Scope: This policy covers all requests for access to BioSpecimens and clinical data managed by the

More information

Bill Coakley, Senior Director, Supply Chain Management, SciClone Pharmaceuticals. Tom Heebink, Business Development/Strategic Alliances/West, BIO

Bill Coakley, Senior Director, Supply Chain Management, SciClone Pharmaceuticals. Tom Heebink, Business Development/Strategic Alliances/West, BIO Consortium Purchasing Unlocking the Value of Collaboration Bill Coakley, Senior Director, Supply Chain Management, SciClone Pharmaceuticals Tom Heebink, Business Development/Strategic Alliances/West, BIO

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (LATIN AMERICA EDITION) Feedback from 58 Latin-American patient groups PUBLISHED JUNE 2016 Que las Compañias Farmacéuticas tengan relación

More information

STATEMENT OF FACTS. 1. Introduction

STATEMENT OF FACTS. 1. Introduction STATEMENT OF FACTS 1. Introduction Telia Company AB (formerly TeliaSonera AB, hereinafter: TeliaSonera ) is an international telecommunications provider, headquartered in Stockholm. TeliaSonera was created

More information

Terms of Reference. Agri-Business Incubator Ethiopia: Strategic Options for Financial Service Offerings, Operating & Financial Model

Terms of Reference. Agri-Business Incubator Ethiopia: Strategic Options for Financial Service Offerings, Operating & Financial Model Terms of Reference Agri-Business Incubator Ethiopia: Strategic Options for Financial Service Offerings, Operating & Financial Model 1 Background Global Programme: Innovation Centers for the Agriculture

More information

Avi-Tech Electronics launches Initial Public Offering of

Avi-Tech Electronics launches Initial Public Offering of AVI-TECH ELECTRONICS LIMITED 19A Serangoon North Avenue 5 Singapore 554859 Tel: (65) 6482 6168 Fax: (65) 6482 6123 Website: http://www.avi-tech.com.sg FOR IMMEDIATE RELEASE Avi-Tech Electronics launches

More information

1. SUMMARY. The participating enterprises reported that they face the following challenges when trying to enter international markets:

1. SUMMARY. The participating enterprises reported that they face the following challenges when trying to enter international markets: 1. SUMMARY Growth-oriented entrepreneurs, especially those in small countries and those that are highly innovative, often look to international markets to grow their business. From a development perspective,

More information

Request for Proposals

Request for Proposals Request for Proposals for Feasibility Study Proposals (PDF) must be received no later than Friday, February 17, 2017 at 12:00 PM (Noon) EST At the following email addresses: bartholemew.smallboy@moosecree.com

More information

Capio Disclosures September Analyst certification. Regulation. Conflicts of interest

Capio Disclosures September Analyst certification. Regulation. Conflicts of interest Capio Disclosures Research reports are prepared by Equity Research, a division of Danske Bank A/S ( Danske Bank ). Analyst certification Each research analyst responsible for the content of research reports

More information

REQUEST FOR PROPOSALS. Guidance Manual on Green Procurement

REQUEST FOR PROPOSALS. Guidance Manual on Green Procurement REQUEST FOR PROPOSALS Guidance Manual on Green Procurement Government of Newfoundland and Labrador Office of Climate Change, Energy Efficiency and Emissions Trading October 7, 2013 1 REQUEST FOR PROPOSALS:

More information

Novel drug development gets an impetus when academia, SME s and global companies combine their strengths. Clinical. Clinical Phase IIa.

Novel drug development gets an impetus when academia, SME s and global companies combine their strengths. Clinical. Clinical Phase IIa. SME Partnership Call Jon de Vlieger & Jorg Janssen April 17, 2012 This presentation has been used during the information session on April 17. The Info Sheet document, version April 20, 2012, contains the

More information

Startup Success Stories

Startup Success Stories Last updated: May 2017 Europe's leading company for online event management and ticketing. Founded in 2006, financing rounds with VC investors and business angels. Winner of the 2009 Techcrunch Europe

More information

Call for abstracts. Submission deadline: 31 st October Submission guidelines

Call for abstracts. Submission deadline: 31 st October Submission guidelines Call for abstracts Submission deadline: 31 st October 2014 Submission guidelines Please read this information carefully before proceeding to the online submission form. The World Confederation for Physical

More information

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist

Pharmacovigilance assessor. National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Senior hospital Pharmacist Curriculum vitae PERSONAL INFORMATION Gyorgyi Fodor WORK EXPERIENCE September 2011 Present Pharmacovigilance assessor National Institute of Pharmacy and Nutrition (OGYÉI) (Hungary) Benefit/risk assessment,

More information

Rationale for Acquisition of St. Paul and Zale Lipshy University Hospitals. History of the UTSW- University Hospital Relationship

Rationale for Acquisition of St. Paul and Zale Lipshy University Hospitals. History of the UTSW- University Hospital Relationship Rationale for Acquisition of St. Paul and Zale Lipshy University Hospitals UT Southwestern Medical Center Presentation to Regents May 12, 2004 History of the UTSW- University Hospital Relationship Growth

More information

BUSINESS INCUBATION TRAINING PROGRAM

BUSINESS INCUBATION TRAINING PROGRAM + INNOVATION & ENTREPRENEURSHIP BUSINESS INCUBATION TRAINING PROGRAM Training Program Overview THE WORLD BANK www.infodev.org INTRODUCTION TO THE TRAINING PROGRAM infodev (www.infodev.org) is a research,

More information

The Language Services Market: 2013

The Language Services Market: 2013 The Language Services Market: 2013 An Annual Review of the Translation, Localization, and Interpreting Services Industry By Donald A. DePalma, Vijayalaxmi Hegde, Hélène Pielmeier, and Robert G. Stewart

More information

Ontario Public Drug Programs

Ontario Public Drug Programs Chapter 3 Section 3.09 Ministry of Health and Long-Term Care Ontario Public Drug Programs Chapter 3 VFM Section 3.09 1.0 Summary About four million Ontarians receive drug coverage through the Ontario Public

More information

Expanding Your Pharmacist Team

Expanding Your Pharmacist Team CALIFORNIA QUALITY COLLABORATIVE CHANGE PACKAGE Expanding Your Pharmacist Team Improving Medication Adherence and Beyond August 2017 TABLE OF CONTENTS Introduction and Purpose 1 The CQC Approach to Addressing

More information

IPO Launch Presentation by Philip Lim. Megachem Limited

IPO Launch Presentation by Philip Lim. Megachem Limited IPO Launch Presentation by Philip Lim Megachem Limited 1 Our Vision A Leading One-Stop Specialty Chemicals Solutions Provider 2 Presentation Outline The Specialty Chemicals Industry Our Business Investment

More information

C L A R I D E N 5-6 November 2014

C L A R I D E N 5-6 November 2014 C L A R I D E N 5-6 November 2014 Knowledge for the world business leaders Mandarin Oriental, Singapore Public Health Emergency Preparedness & Response Management in Singapore Faculty Directors Dr. Teoh

More information

Surgical Critical Care Sub I

Surgical Critical Care Sub I Course Goals Goals 1. Develop the attitude, skills, and knowledge to be able to recognize the impact of the global and local health care system and its impact on patient outcomes. 2. Develop the attitude,

More information

Regulatory Submissions Trends Survey 2002 Ellen Semple Date received (in revised form): 18th March, 2003

Regulatory Submissions Trends Survey 2002 Ellen Semple Date received (in revised form): 18th March, 2003 Ellen Semple joined CDC Solutions in July 2002 and is VP of Global Marketing. She oversees the strategic direction of CDC Solutions global marketing teams and works directly with CDC s work headquarters

More information

UBM CAPITAL MARKETS DAY

UBM CAPITAL MARKETS DAY UBM CAPITAL MARKETS DAY Capital Markets Day Introduction Disclaimer This presentation contains statements which are not based on current or historical fact and which are forward looking in nature. These

More information

Australia s Life Sciences Sector Snapshot 2017

Australia s Life Sciences Sector Snapshot 2017 Australia s Life Sciences Sector Snapshot 2017 Conducted by Australia s Life Sciences Sector Snapshot 2017 1 2 Australia s Life Sciences Sector Snapshot 2017 Contents Executive Summary 5 Key Findings 8

More information

TOURISM TRANSFORMATION FUND PROGRAMME GUIDELINES

TOURISM TRANSFORMATION FUND PROGRAMME GUIDELINES TOURISM TRANSFORMATION FUND PROGRAMME GUIDELINES 1. PREAMBLE The purpose of this document is to provide guidance to applicants submitting proposals for funding consideration under the Tourism Transformation

More information

PCSK9 Competitive Grant Program

PCSK9 Competitive Grant Program PCSK9 Competitive Grant Program An independently-reviewed competitive grant program supported by Amgen to fund innovative research advancing the understanding of PCSK9 and atherosclerosis PCSK9 Competitive

More information

SUNDAY, SEPTEMBER 18, 2016

SUNDAY, SEPTEMBER 18, 2016 AACR Translational Cancer Research for Basic Scientists Workshop September 18-23, 2016 Hilton Boston Back Bay Hotel Boston, Massachusetts CHAIRPERSONS: Tom Curran, PhD, Children s Mercy Hospital, Kansas

More information

Submission to the R&D tax environment review

Submission to the R&D tax environment review Submission to the R&D tax environment review BioIndustry Association February 2017 Summary The UK s world-leading life sciences sector contributes more than 60bn a year to GDP 1, and generates exports

More information

Understand expectations of labour market in Switzerland and handle your job search successfully

Understand expectations of labour market in Switzerland and handle your job search successfully Understand expectations of labour market in Switzerland and handle your job search successfully Topics: How the Swiss Job Market works: agencies, head hunters and job portals Composing a CV and selling

More information

Infectious Diseases Elective PL1 Residents

Infectious Diseases Elective PL1 Residents PL1 Residents The elective rotation for residents in Pediatric Infectious Disease provides a broad learning experience for residents at all levels of training through provision of care for children requiring

More information